Mineralocorticoid receptors modulate vascular endothelial function in human obesity

Clinical Science

Volumn 125, Issue 11, 2013, Pages 513-520

  Hwang, Moon Hyon ^a   Yoo, Jeung Ki ^a   Luttrell, Meredith ^b   Kim, Han Kyul ^a   Meade, Thomas H ^b   English, Mark ^c   Segal, Mark S ^d   Christou, Demetra D ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Abdominal visceral and subcutaneous fat; Brachial artery; Flow mediated dilation; Mineralocorticoid receptor; Obesity

Indexed keywords

3 NITROTYROSINE; EPLERENONE; ISOPROSTANE DERIVATIVE; MINERALOCORTICOID RECEPTOR; PLACEBO; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; BODY FAT; BODY MASS; BRACHIAL ARTERY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; ENDOTHELIUM CELL; FEMALE; HUMAN; INTRAABDOMINAL FAT; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SHEAR STRESS; SUBCUTANEOUS FAT; VASCULAR ENDOTHELIUM;

ABDOMINAL FAT; AGED; BODY COMPOSITION; BODY MASS INDEX; BRACHIAL ARTERY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIAL CELLS; F2-ISOPROSTANES; FEMALE; HUMANS; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; NADPH OXIDASE; OBESITY; OXIDATIVE STRESS; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE; TYROSINE;

EID: 84881233385     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130200     Document Type: Article

References (46)

1. World Health Organization (2013) Obesity and overweight fact, Fact Sheet No. 311, http://www.who.int/mediacentre/ factsheets/fs311/en/
2. Ogden, C. L., Carroll, M. D., Kit, B. K. and Flegal, K. M. (2012) Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief, pp. 1-8
3. Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X. and Eckel, R. H. (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113, 898-918
4. Rossignol, P., Menard, J., Fay, R., Gustafsson, F., Pitt, B. and Zannad, F. (2011) Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J. Am. Coll. Cardiol. 58, 1958-1966
5. Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J. and Gatlin, M. (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309-1321
6. Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J. and Wittes, J. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341, 709-717
7. Williams, G. H. (2005) Aldosterone biosynthesis, regulation, and classical mechanism of action. Heart Fail. Rev. 10, 7-13
8. McCurley, A. and Jaffe, I. Z. (2012) Mineralocorticoid receptors in vascular function and disease. Mol. Cell. Endocrinol. 350, 256-265
9. Nguyen Dinh Cat, A., Briones, A. M., Callera, G. E., Yogi, A., He, Y., Montezano, A. C. and Touyz, R. M. (2011) Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors. Hypertension 58, 479-488
10. Briones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Correa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P. et al. (2012) Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 59, 1069-1078
11. Rossi, G. P., Belfiore, A., Bernini, G., Fabris, B., Caridi, G., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mannelli, M. et al. (2008) Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J. Clin. Endocrinol. Metab. 93, 2566-2571
12. Kidambi, S., Kotchen, J. M., Krishnaswami, S., Grim, C. E. and Kotchen, T. A. (2009) Aldosterone contributes to blood pressure variance and to likelihood of hypertension in normal-weight and overweight African Americans. Am. J. Hypertens. 22, 1303-1308
13. Goodfriend, T. L., Egan, B. M. and Kelley, D. E. (1999) Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot. Essent. Fatty Acids 60, 401-405
14. Engeli, S., Bohnke, J., Gorzelniak, K., Janke, J., Schling, P., Bader, M., Luft, F. C. and Sharma, A. M. (2005) Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45, 356-362
15. Bentley-Lewis, R., Adler, G. K., Perlstein, T., Seely, E. W., Hopkins, P. N., Williams, G. H. and Garg, R. (2007) Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J. Clin. Endocrinol. Metab. 92, 4472-4475
16. Andronico, G., Cottone, S., Mangano, M. T., Ferraro-Mortellaro, R., Baiardi, G., Grassi, N., Ferrara, L., Mule, G. and Cerasola, G. (2001) Insulin, renin-aldosterone system and blood pressure in obese people. Int. J. Obes. Relat. Metab. Disord. 25, 239-242
17. Tuck, M. L., Sowers, J., Dornfeld, L., Kledzik, G. and Maxwell, M. (1981) The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N. Engl. J. Med. 304, 930-933
18. Rocchini, A. P., Katch, V. L., Grekin, R., Moorehead, C. and Anderson, J. (1986) Role for aldosterone in blood pressure regulation of obese adolescents. Am. J. Cardiol. 57, 613-618
19. Dall'Asta, C., Vedani, P., Manunta, P., Pizzocri, P., Marchi, M., Paganelli, M., Folli, F. and Pontiroli, A. E. (2009) Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity. Nutr. Metab. Cardiovasc. Dis. 19, 110-114
20. Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G. and Baron, A. D. (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97, 2601-2610
21. Arcaro, G., Zamboni, M., Rossi, L., Turcato, E., Covi, G., Armellini, F., Bosello, O. and Lechi, A. (1999) Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int. J. Obes. Relat. Metab. Disord. 23, 936-942
22. Ras, R. T., Streppel, M. T., Draijer, R. and Zock, P. L. (2012) Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int. J. Cardiol., doi:10.1016/j.ijcard.2012.09.047
23. Vita, J. A. (2011) Endothelial function. Circulation 124, e906-e912
24. Cai, H. and Harrison, D. G. (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844
25. Avogaro, A. and de Kreutzenberg, S. V. (2005) Mechanisms of endothelial dysfunction in obesity. Clin. Chim. Acta 360, 9-26
26. Keidar, S., Kaplan, M., Pavlotzky, E., Coleman, R., Hayek, T., Hamoud, S. and Aviram, M. (2004) Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation 109, 2213-2220
27. Rajagopalan, S., Duquaine, D., King, S., Pitt, B. and Patel, P. (2002) Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation 105, 2212-2216
28. Thai, H. M., Do, B. Q., Tran, T. D., Gaballa, M. A. and Goldman, S. (2006) Aldosterone antagonism improves endothelial-dependent vasorelaxation in heart failure via upregulation of endothelial nitric oxide synthase production. J. Card. Fail. 12, 240-245
29. Sartorio, C. L., Fraccarollo, D., Galuppo, P., Leutke, M., Ertl, G., Stefanon, I. and Bauersachs, J. (2007) Mineralocorticoid receptor blockade improves vasomotor dysfunction and vascular oxidative stress early after myocardial infarction. Hypertension 50, 919-925
30. Farquharson, C. A. and Struthers, A. D. (2000) Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation 101, 594-597
31. Abiose, A. K., Mansoor, G. A., Barry, M., Soucier, R., Nair, C. K. and Hager, D. (2004) Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy. Am. J. Cardiol. 93, 1564-1566
32. Corretti, M. C., Anderson, T. J., Benjamin, E. J., Celermajer, D., Charbonneau, F., Creager, M. A., Deanfield, J., Drexler, H., Gerhard-Herman, M., Herrington, D. et al. (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 39, 257-265
33. Erratum (2002) J. Am. Coll. Cardiol. 39, 1082
34. Thijssen, D. H., Black, M. A., Pyke, K. E., Padilla, J., Atkinson, G., Harris, R. A., Parker, B., Widlansky, M. E., Tschakovsky, M. E. and Green, D. J. (2011) Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am. J. Physiol. Heart Circ. Physiol. 300, H2-H12
35. Mitchell, G. F., Parise, H., Vita, J. A., Larson, M. G., Warner, E.,Keaney, Jr, J. F., Keyes, M. J., Levy, D., Vasan, R. S. and Benjamin, E. J.(2004) Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension 44, 134-139
36. Colombo, P. C., Ashton, A. W., Celaj, S., Talreja, A., Banchs, J. E., Dubois, N. B., Marinaccio, M., Malla, S., Lachmann, J., Ware, J. A. et al. (2002) Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium. J. Appl. Physiol. 92, 1331-1338
37. Silver, A., Beske, S. D., Christou, D. D., Donato, A. J., Moreau, K. L., Eskurza, I., Gates, P. E. and Seals, D. R. (2007) Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47phox expression and evidence of endothelial oxidative stress. Circulation 115, 627-637
38. Silver, A. E., Christou, D. D., Donato, A. J., Beske, S. D., Moreau, K. L., Magerko, K. A. and Seals, D. R. (2010) Protein expression in vascular endothelial cells obtained from human peripheral arteries and veins. J. Vasc. Res. 47, 1-8
39. Shenouda, S. M., Widlansky, M. E., Chen, K., Xu, G., Holbrook, M., Tabit, C. E., Hamburg, N. M., Frame, A. A., Caiano, T. L., Kluge, M. A. et al. (2011) Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation 124, 444-453
40. Milne, G. L., Sanchez, S. C., Musiek, E. S. and Morrow, J. D. (2007) Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat. Protoc. 2, 221-226
41. Christou, D. D., Gentile, C. L., DeSouza, C. A., Seals, D. R. and Gates, P. E. (2005) Fatness is a better predictor of cardiovascular disease risk factor profile than aerobic fitness in healthy men. Circulation 111, 1904-1914
42. Christou, D. D., Pierce, G. L., Walker, A. E., Hwang, M. H., Yoo, J. K., Luttrell, M., Meade, T. H., English, M. and Seals, D. R. (2012) Vascular smooth muscle responsiveness to nitric oxide is reduced in healthy adults with increased adiposity. Am. J. Physiol. Heart Circ. Physiol. 303, H743-H750
43. Khosla, N., Kalaitzidis, R. and Bakris, G. L. (2009) Predictors of hyperkalemia risk following hypertension control with aldosterone blockade. Am. J. Nephrol. 30, 418-424
44. de Souza, F., Muxfeldt, E., Fiszman, R. and Salles, G. (2010) Efficacy of spironolactone therapy in patients with true resistant hypertension. Hypertension 55, 147-152
45. Bender, S. B., McGraw, A. P., Jaffe, I. Z. and Sowers, J. R. (2013) Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?. Diabetes 62, 313-319
46. Funder, J. W. (2010) Aldosterone and mineralocorticoid receptors in the cardiovascular system. Prog. Cardiovasc. Dis. 52, 393-400